Quick Answer
Amneal Pharmaceuticals, Inc. reported Diluted EPS of $0.22 per share for fiscal year 2025.
Amneal Pharmaceuticals, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.22 | +157.9% |
| 2024 | -$0.38 | +20.8% |
| 2023 | -$0.48 | +44.2% |
| 2022 | -$0.86 | -1328.6% |
| 2021 | $0.07 | -88.5% |
| 2020 | $0.61 | +122.3% |
| 2019 | -$2.74 | -1612.5% |
| 2018 | -$0.16 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.01 | — | -85.7% |
| June 30, 2025 | $0.07 | +250.0% | +75.0% |
| March 31, 2025 | $0.04 | +113.3% | — |
| September 30, 2024 | $0.00 | -100.0% | -100.0% |
| June 30, 2024 | $0.02 | -75.0% | +106.7% |
| March 31, 2024 | -$0.30 | -500.0% | -600.0% |
| September 30, 2023 | $0.06 | +400.0% | -25.0% |
| June 30, 2023 | $0.08 | +110.0% | +260.0% |
- Amneal Pharmaceuticals, Inc. showed an increase of +157.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2018–2025 period, Amneal Pharmaceuticals, Inc.’s diluted eps has grown by 237.5% (from $0.16 per share (loss) to $0.22 per share).
- The most recent figure is from Amneal Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: